Find the Perfect Plan for Your Investment Journey
D
Latest price
52 Week Range
R$7.83 - R$11.58
Next Earnings Date
May 07 2025
Next Earnings Date
May 07 2025
Latest price
Market Cap | R$1.30B |
EV | R$2.32B |
Shares Outstanding | 148.79M |
Beta | 0.44 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | R$11.80 |
P/E 2025E | 8.46x |
P/Revenue 2025E | 0.23x |
Revenue | 15.30% |
EPS | 9.70% |
Operating Cash Flow | 19.60% |
Free Cash Flow | - |
Revenue | 11.90% |
EPS | 34.40% |
Operating Cash Flow | 18.10% |
Free Cash Flow | -31.30% |
Gross Margin 2025E | 30.28% |
Net Profit Margin 2025E | 2.56% |
ROE 2025E | 10.53% |
ROCE 2024 | 8.76% |
DPS 2025E | R$0.42 |
Payout Ratio 2025E | 40.78% |
Div. Yield 2025E | 4.82% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
D
Dimed S.A. Distribuidora de Medicamentos
PNVL3
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mottin Neto, Julio
Employees
11,108
Website
www.dimed.com.brIPO Date
2000-01-03
Headquarters
Building 100, Avenida Industrial Belgraff, 865, Eldorado do Sul, Rio Grande do Sul, 92990-000, Brazil
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved